GSE155987 LMTK2 knockdown CFBE41o- 0 v 1 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE155987_LMTK2 knockdown_CFBE41o-_0_v_1_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE155987_LMTK2 knockdown_CFBE41o-_0_v_1_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE155987_LMTK2 knockdown_CFBE41o-_0_v_1_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE155987_LMTK2 knockdown_CFBE41o-_0_v_1_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

HLA complex P5

Gene

double homeobox A pseudogene 8

Gene

long intergenic non-protein coding RNA 511

Gene

FGD5 antisense RNA 1

Gene

USP2 antisense RNA 1

Gene

uncharacterized LOC645485

Gene

long intergenic non-protein coding RNA 869

Gene

NF-kappaB interacting lncRNA

Gene

long intergenic non-protein coding RNA 1138

Gene

MIR193b-365a host gene


  • Gene

    double homeobox A pseudogene 8


  • Gene

    long intergenic non-protein coding RNA 511


  • Gene

    FGD5 antisense RNA 1


  • Gene

    USP2 antisense RNA 1


  • Gene

    uncharacterized LOC645485


  • Gene

    long intergenic non-protein coding RNA 869


  • Gene

    NF-kappaB interacting lncRNA


  • Gene

    long intergenic non-protein coding RNA 1138


  • Gene

    MIR193b-365a host gene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.